For people living with type 1 diabetes, fear has long occupied the space where intimacy should be — a quiet, unspoken anxiety that sex might trigger a dangerous drop in blood sugar. A new study presented in Milan is the first to actually measure what happens, tracking 110 sexual encounters across 12 patients and finding no clinically significant hypoglycemia in any of them. The research, born from the simple act of asking patients what they feared, offers something medicine rarely delivers so directly: permission to stop being afraid.
Study: Sexual activity safe for type 1 diabetes patients using glucose monitors
Sex life is central to quality of life, and fear can lead people to avoid intimacy.
So the headline here is basically that sex is safe for type 1 diabetes patients. But safe compared to what? What was the actual risk before?
That's the thing—nobody really knew. There was fear, clearly documented in surveys, but no objective measurement of blood sugar during sex. The researchers found no clinically significant hypoglycemia in 110 sexual events, which is reassuring, but it doesn't mean there was never a risk. It means this particular group, with CGM devices, didn't experience dangerous drops.
Right, and that's a crucial limitation. This is 12 people over three months. That's a small sample. And they were all using continuous glucose monitoring—which is not universal among type 1 diabetes patients. The findings can't tell us anything about people without CGM access.
True, but the study does something important: it breaks the silence. Patients told the researchers they were afraid to talk about sex with their doctors. Now there's actual data to discuss. That changes the conversation.
The blood sugar responses seem pretty variable—sometimes it goes down, sometimes up. How much does that complicate the message?
It actually makes it more nuanced and probably more credible. If the study had found that sex always lowered glucose or always raised it, that would be simpler but less true to what actually happens. The variability is real, and it's influenced by things patients can understand: their starting glucose level, what time of day it is, their body composition.
But the study doesn't tell us how to manage that variability. It says glucose responses are influenced by pre-activity glucose level, but it doesn't say what patients should do about it. Should they eat before sex? Adjust insulin? The study doesn't answer that.
No, it doesn't. That's future work. This study is about measurement and reassurance. It's saying: this activity does not appear to be inherently dangerous. That's the first step.
What about the people without CGM devices? The researchers mention them at the end.
They point out that without continuous monitoring, people have no idea what their blood sugar is doing during sex—or during anything else. So the safety findings here don't apply to them. It's a reminder that access to technology shapes what we can know and what we can safely do.
And that's a real equity issue. CGM devices aren't universally available or affordable. So this reassurance is available to some patients but not others.
So what changes because of this study?
Doctors now have data to discuss with patients. Instead of silence or vague warnings, they can say: we measured this, and it's not causing dangerous hypoglycemia. That might help people feel less isolated and less afraid. And that matters for quality of life.
Le Pouls
- For years, one in three young adults with type 1 diabetes has reported anxiety about low blood sugar during sex — a fear real enough to quietly erode intimacy and quality of life.
- The danger felt logical: sex burns energy, energy expenditure can crash glucose levels, and nighttime activity leaves dangerous drops undetected — yet no one had ever actually measured what happens.
- Researchers in Warsaw strapped continuous glucose monitors to 12 patients, logged 110 sexual encounters over three months, and watched the numbers — finding no clinically significant hypoglycemia in any event, even at night.
- Blood sugar responses proved individual and unpredictable — falling after 58% of encounters, rising after 42% — shaped by starting glucose levels, body mass index, and time of day.
- The reassurance comes with a hard boundary: these findings protect only those with access to continuous glucose monitoring, leaving patients without that technology still navigating the dark.
For people living with type 1 diabetes, fear has long occupied the space where intimacy should be — a quiet, unspoken anxiety that sex might trigger a dangerous drop in blood sugar. A new study presented in Milan is the first to actually measure what happens, tracking 110 sexual encounters across 12 patients and finding no clinically significant hypoglycemia in any of them. The research, born from the simple act of asking patients what they feared, offers something medicine rarely delivers so directly: permission to stop being afraid.
For people with type 1 diabetes, the fear of a blood sugar crash during sex has long been a quiet barrier to intimacy. Sexual activity burns energy, energy expenditure can trigger hypoglycemia, and the worry — though rarely spoken aloud — has kept many patients at a distance from their own lives. No one, until now, had actually measured what happens.
Dr. Dominica Orłowska and colleagues at the Medical University of Warsaw started by asking their patients what they feared. The answer was clear. A 2017 survey had already found roughly one in three young adults with type 1 diabetes reported anxiety about low blood sugar during intercourse — but all the evidence came from questionnaires. No one had looked at the numbers.
The distinction matters because sex is not like exercise. A workout can be planned for — insulin adjusted, a snack eaten, a pump switched to activity mode. Sex is usually spontaneous, often happening at night, precisely when unrecognized hypoglycemia is most dangerous. And almost no one discusses it with their doctor, leaving the fear intact and the silence unbroken.
The study followed 12 adults with type 1 diabetes over three months, all wearing continuous glucose monitors. Participants logged 110 sexual encounters, and researchers analyzed blood sugar readings from two hours before to six hours after each event. No clinically significant hypoglycemia occurred in any of them.
The patterns, however, were more nuanced than a simple reassurance. Glucose dropped after 58% of encounters and rose after 42% — both directions appearing in every participant. What determined the outcome was largely the starting glucose level, the time of day, and body mass index. Nighttime activity produced a statistically significant drop; daytime activity showed almost no change.
The researchers conclude that sexual activity does not appear to raise the risk of dangerous hypoglycemia for type 1 diabetes patients — findings that could finally give clinicians something concrete to offer patients who have never been asked. But they add a critical caveat: these reassurances apply only to those using continuous glucose monitoring. For patients without access to that technology, the physiology remains invisible, and the fear, for now, remains unresolved.
For people living with type 1 diabetes, the fear of a dangerous drop in blood sugar during sex has long been a quiet barrier to intimacy. The worry is real enough—sexual activity burns energy, and energy expenditure can trigger hypoglycemia, that sudden plunge in glucose that demands immediate attention. But until now, no one had actually measured what happens to blood sugar during sex. A new study presented at the European Association for the Study of Diabetes annual meeting in Milan does exactly that, and the findings offer reassurance that may help patients reclaim a part of their lives they've been avoiding.
Dr. Dominica Orłowska and colleagues at the Medical University of Warsaw began this work by simply asking their patients what they feared. When they did, the answer came back clearly: yes, hypoglycemia during sex happens, or at least the fear of it does. A 2017 survey of 53 young adults with type 1 diabetes found that roughly one in three reported anxiety about low blood sugar during intercourse. But all the existing evidence came from questionnaires and interviews—no one had ever actually looked at the numbers.
The distinction matters more than it might seem. Exercise is physical exertion, and it lowers glucose in predictable ways. But sex is different in practice, Orłowska explains. You can plan for a workout—reduce your insulin dose beforehand, eat something, switch your pump to activity mode. Sex, though, is usually spontaneous. It often happens in the evening or at night, precisely when the risk of severe, unrecognized hypoglycemia is highest. And almost no one talks about it with their doctor. Patients will discuss their exercise routine with their diabetologist and get concrete guidance, but sex remains unmentioned, leaving the fear unaddressed and the silence intact.
The study tracked 12 adults with type 1 diabetes—seven women and five men, with a median age of 36—over three months. All wore continuous glucose monitoring devices, either FreeStyle Libre 2 or Guardian 4. Half were on multiple daily insulin injections; the other half used insulin pumps, including two with automated insulin delivery systems. Participants logged their sexual activity in their CGM app, and researchers analyzed blood sugar readings from two hours before to six hours after each event. In total, 110 sexual encounters were recorded.
The results were reassuring. No clinically significant hypoglycemia occurred in any of the events. But the blood sugar patterns themselves were more complex than a simple prediction would suggest. In 58 percent of the encounters—64 events—glucose dropped after sex, falling on average from 180 to 132 mg/dL. In the remaining 42 percent, glucose rose, climbing from 122 to 164 mg/dL. Both patterns appeared in every participant, sometimes dropping, sometimes rising, depending on circumstances.
What determined which way the blood sugar moved? The glucose level before sex mattered most. Higher starting glucose led to bigger drops afterward; lower starting glucose led to smaller increases. Timing of day also played a role. Nighttime sexual activity—66 of the 110 events—produced a statistically significant glucose decrease, from 165 to 147 mg/dL. Daytime activity, by contrast, showed essentially no change. Body mass index influenced the response too: participants with a BMI of 25 or higher showed greater glucose decreases than those below that threshold.
The authors conclude that sexual intercourse in adults with type 1 diabetes does not appear to increase the risk of clinically significant hypoglycemia, even when it occurs at night. The blood sugar response is individual and bidirectional, shaped by starting glucose level, BMI, and time of day. These findings, they suggest, could support clinical counseling and help reduce the fear-driven avoidance of sexual activity that has become a quality-of-life issue for many people with diabetes.
But the researchers add an important caveat: these reassurances apply to people using continuous glucose monitoring. For those without access to CGM technology, the picture remains unclear. They may have no way of knowing whether hypoglycemia is occurring during sex—or during any other activity. The safety of sexual activity for type 1 diabetes patients, it turns out, depends not just on physiology but on access to the tools that make that physiology visible.
Citations marquantes
Sex is physical exertion like any other, but in practice it is different. Exercise can be planned for, but sexual activity is usually spontaneous and often happens at night, when the risk of severe hypoglycemia is greatest.— Dr. Dominica Orłowska, Medical University of Warsaw
Sexual intercourse in adults with type 1 diabetes does not appear to increase the risk of clinically significant hypoglycemia, even at night. These findings may support clinical counselling and help reduce hypoglycaemia fear-related avoidance of sexual activity.— Study authors